PRSS3 and Cowden disease: As de- and transamidation of gliadin peptides appear to be a major event, one can assume that dysregulation of TG2 activity, or additional transglutaminase activity e.g., by mTG could play a role in CD pathogenesis and might reveal potential therapeutic targets [26].